The global ascites market size was valued at USD 2.2 billion in 2023, driven by the increasing prevalence of the disease, along with growing health consciousness R&D activities, across the globe. The market size is anticipated to grow at a CAGR of 4.3% during the forecast period of 2024-2032 to achieve a value of USD 3.1 billion by 2032.
Ascites: Introduction
Ascites is a medical condition characterized by the abnormal accumulation of fluid in the abdominal cavity. This condition results from various underlying causes, including liver disease (such as cirrhosis), heart failure, kidney disease, and certain cancers. As fluid accumulates, the abdomen becomes distended, leading to abdominal discomfort, swelling, and a feeling of fullness. Ascites can be diagnosed through physical examination, imaging, and laboratory tests. Treatment typically focuses on addressing the underlying cause, such as managing liver disease or heart failure, and may involve dietary sodium restrictions, diuretics, and, in severe cases, drainage of the fluid using a procedure called paracentesis.
Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/ascites-market/requestsample
Key Trends in the Global Ascites Market
The global rise in cases of cirrhosis, often attributed to excessive alcohol consumption, hepatitis B and C infections, and non-alcoholic steatohepatitis (NASH), has contributed significantly to the ascites market’s expansion. There’s a growing trend of adopting advanced diagnostic modalities, including sophisticated imaging techniques and laboratory tests. These tools not only help in the early detection of ascites but also assist in determining their underlying cause.
Paracentesis, a procedure where fluid is removed from the abdomen using a needle, has seen advancements in terms of equipment and technique. The shift towards minimally invasive procedures ensures reduced recovery times and fewer complications. Research and development aimed at producing effective drugs for cirrhosis and other liver diseases are on the rise. This is not only to treat ascites but to address its root cause, thereby providing a more holistic approach to patient care.
Emerging economies are witnessing increased awareness about liver diseases and their complications. This, combined with the gradual improvement in medical infrastructure, is fueling the ascites market growth in these regions. There is a growing trend of collaborations between pharmaceutical companies, biotech firms, and academic institutions. These partnerships aim to expedite the discovery of novel treatments and improve existing therapeutic options.
To curb the rising incidence of liver diseases and associated complications like ascites, governments and healthcare organizations worldwide are initiating awareness campaigns. These programs emphasize early diagnosis, appropriate treatment, and lifestyle changes to prevent disease progression.
Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/ascites-market
Global Ascites Market Segmentation
Market Breakup by Treatment
- Medicinal Therapy
- Diuretics
- Antibiotics
- Surgery
- Paracentesis
- Others
Market Breakup by Diagnosis
- Ultrasound
- CT Scan
- MRI
- Blood Test
- Laparoscopy
- Angiography
- Others
Market Breakup by Route of Administration
- Oral
- Parenteral
- Others
Market Breakup by End User
- Hospitals & Clinics
- Research and Academic Laboratories
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Ascites Market Overview
North America holds a significant portion of the ascites market, primarily due to the high prevalence of liver diseases, especially cirrhosis resulting from alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and hepatitis. The availability of advanced diagnostic modalities, increasing R&D for treatment options, and favorable insurance reimbursement policies contribute to the market’s growth.
Europe, especially Western European countries, has a mature market for ascites diagnosis and treatment, given the region’s advanced healthcare infrastructure. Similar to North America, alcohol-related liver disease, hepatitis, and increasing cases of NAFLD drive the ascites market. Additionally, the availability of advanced treatment modalities and a focus on research contribute to market growth.
APAC is witnessing a growing ascites market due to its vast population base and increasing prevalence of liver diseases. The rise in alcohol consumption in certain countries, coupled with the prevalence of viral hepatitis (especially hepatitis B and C), drives the need for ascites management. However, limited access to advanced healthcare in certain areas might pose challenges.
Latin America has a growing ascites market, driven by countries with improving healthcare infrastructure, like Brazil, Argentina, and Mexico. The prevalence of alcoholic liver disease and viral hepatitis, especially hepatitis C, are prominent factors. Efforts to enhance healthcare infrastructure and the adoption of modern diagnostic and treatment modalities are evident.
Global Ascites Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Becton, Dickinson and Company
- BioVie Inc.
- Sequana Medical NV
- Sanofi Inc.
- Hoffmann-La Roche Ltd.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- WOCKHARDT
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organization’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
